Organizations Filed Purposes:
THE ORGANIZATION IS ADVANCING UMBILICAL CORD BLOOD CELL THERAPY TREATMENTS: SAVING LIVES, ENHANCING HEALTH, AND EXPANDING KNOWLEDGE ONE BIRTH AT A TIME.
THE ORGANIZATION'S VISION STATEMENT ENCOMPASSES A WORLD IN WHICH CORD BLOOD THERAPIES ENHANCE QUALITY OF LIFE FOR ALL.THE ORGANIZATION'S CORE VALUES ARE QUALITY, COLLABORATION, INNOVATION, LEADERSHIP, COMPASSION, AND INTERGRITY.
THE ORGANIZATION HAS BEEN ESTABLISHED TO HARVEST, PROCESS, AND UTILIZE UMBILICAL CORD BLOOD ("UCB") STEM CELLS FOR CLINICAL TRANSPLANTATION, MEDICAL RESEARCH, AND DISTRIBUTION, AND TO PROVIDE EDUCATION TO PHYSICIANS AND THE PUBLIC AT LARGE ON ADVANCES IN THE UTILIZATION OF UCB-DERIVED STEM CELLS FOR THE TREATMENT OF CANCER AND OTHER DISEASES.
BEGINNING IN 2014, THE ORGANIZATION PERFORMS LABORATORY RESEARCH IN CELL THERAPEUTICS WITH FOUR STUDIES CURRENTLY IN PROGRESS.
THE CORD BLOOD CENTER IS ESTABLISHING A CELL THERAPY INCUBATOR (CTI) TO DEVELOP NEW STEM CELL THERAPIES USING CORD BLOOD.
Executives Listed on Filing
Total Salary includes financial earnings, benefits, and all related organization earnings listed on tax filing
| Name | Title | Hours Per Week | Total Salary |
|---|
| Wouter Van'T Hof | CORD BLOOD BANK DIRECTOR | 40 | $159,149 |
| Mary J Laughlin | MEDICAL DIRECTOR | 20 | $153,142 |
| Marcie Finney | EXECUTIVE DIRECTOR | 40 | $151,186 |
| Lisa Phillips-Johnson | QUALITY & REGULATORY DIRECTOR | 30 | $103,540 |
| David Woolf | DIRECTOR | 1 | $0 |
| Pablo Rubinstein | DIRECTOR | 1 | $0 |
| Bruce Goodman | CHAIRMAN, DIRECTOR | 2 | $0 |
| Alexander Katz | TREASURER, DIRECTOR | 2 | $0 |
Data for this page was sourced from XML published by IRS (
public 990 form dataset) from:
https://s3.amazonaws.com/irs-form-990/202042729349301164_public.xml